Progressive Multifocal Leukoencephalopathy Innovations|omicsgroup|Journal Of Multiple Sclerosis

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Global Neuroscience and Neurology Conference

Webinar, Webinar

Annual Summit on Neurological Disorders & Stroke

Webinar, Webinar

Progressive Multifocal Leukoencephalopathy Innovations

Progressive Multifocal Leukoencephalopathy is a rare disease caused by JC virus infection and thus loss of myelin. Progressive multifocal leukoencephalopathy (PML) is a disorder of the central nervous system caused by the JC virus. The JC virus, a human polyoma virus, is found widespread over the globe. This disease is very closely related to multiple sclerosis. The disease causes one specific lesion in the brain. PML is often considered as a fatal disease of the central nervous system most commonly associated with severe immunodeficiency syndrome. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2021